Gastroretentive drug delivery system of ranitidine hydrochloride: Formulation and in vitro evaluation

被引:136
作者
Dave, BS [1 ]
Amin, AF [1 ]
Patel, MM [1 ]
机构
[1] Shree SK Patel Coll Pharmaceut Educ & Res, Ganpat Vidyanagar, India
关键词
ranitidine hydrochloride; gastroretentive; floating drug delivery; sustained release;
D O I
10.1208/pt050234
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The purpose of this research was to prepare a gastroretentive drug delivery system of ranitidine hydrochloride. Guar gum, xanthan gum, and hydroxypropyl methylcellulose were evaluated for gel- forming properties. Sodium bicarbonate was incorporated as a gas- generating agent. The effects of citric acid and stearic acid on drug release profile and floating properties were investigated. The addition of stearic acid reduces the drug dissolution due to its hydrophobic nature. A 32 full factorial design was applied to systemically optimize the drug release profile. The amounts of citric acid anhydrous ( X-1) and stearic acid ( X-2) were selected as independent variables. The times required for 50% ( t(50)) and 80% drug dissolution ( t(80)), and the similarity factor f(2) were selected as dependent variables. The results of the full factorial design indicated that a low amount of citric acid and a high amount of stearic acid favors sustained release of ranitidine hydrochloride from a gastroretentive formulation. A theoretical dissolution profile was generated using pharmacokinetic parameters of ranitidine hydrochloride. The similarity factor f2 was applied between the factorial design batches and the theoretical dissolution profile. No significant difference was observed between the desired release profile and batches F2, F3, F6, and F9. Batch F9 showed the highest f2 ( f2 = 75) among all the batches, and this similarity is also reflected in t(50) (similar to 214 minutes) and t(80) (similar to 537 minutes) values. These studies indicate that the proper balance between a release rate enhancer and a release rate retardant can produce a drug dissolution profile similar to a theoretical dissolution profile.
引用
收藏
页数:6
相关论文
共 28 条
[1]
RELEASE MECHANISMS IN GELFORMING SUSTAINED-RELEASE PREPARATIONS [J].
BAMBA, M ;
PUISIEUX, F ;
MARTY, JP ;
CARSTENSEN, JT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1979, 2 (5-6) :307-315
[2]
Colonic metabolism of ranitidine: implications for its delivery and absorption [J].
Basit, AW ;
Lacey, LF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 227 (1-2) :157-165
[3]
Chawla G, 2003, PHARM TECH, V27, P50
[4]
INFLUENCE OF SHAPE FACTORS ON KINETICS OF DRUG RELEASE FROM MATRIX TABLETS .2. EXPERIMENTAL [J].
COBBY, J ;
MAYERSOHN, M ;
WALKER, GC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (05) :732-737
[5]
Coffin M., 1995, US Patent, Patent No. [5 407 687, 5407687]
[6]
Ranitidine HCl: Tablet film coating acidity and discoloration [J].
Eyjolfsson, R .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (06) :693-694
[7]
ESTABLISHMENT OF SINK CONDITIONS IN DISSOLUTION RATE DETERMINATIONS - THEORETICAL CONSIDERATIONS AND APPLICATION TO NONDISINTEGRATING DOSAGE FORMS [J].
GIBALDI, M ;
FELDMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (10) :1238-&
[8]
METHODS OF EXPRESSING DISSOLUTION RATE DATA [J].
GOLDSMITH, JA ;
RANDALL, N ;
ROSS, SD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (06) :347-349
[9]
RANITIDINE - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN PEPTIC-ULCER DISEASE AND OTHER ALLIED DISEASES [J].
GRANT, SM ;
LANGTRY, HD ;
BROGDEN, RN .
DRUGS, 1989, 37 (06) :801-870
[10]
*GUID IND SUPAC MR, MOD REL SOL OR DOS F